Song Hong Fang
SEC insider (Form 3/4/5 filer). CIK 0002008157. Director at CG Oncology, Inc. (CGON). 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2025. Located in WANCHAI, K3.
Companies Song Hong Fang has filed insider reports for
- CG Oncology, Inc. (CGON): Director
Song Hong Fang
CIK: 0002008157
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CG Oncology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Sep 3, 2025CGON
CG Oncology, Inc.
SaleIndirect100 shares at avg. $28.99$3K - Sep 3, 2025CGON
CG Oncology, Inc.
SaleIndirect30.1K shares at avg. $28.24$850K - Sep 3, 2025CGON
CG Oncology, Inc.
SaleIndirect100 shares at avg. $28.96$3K - Sep 3, 2025CGON
CG Oncology, Inc.
SaleIndirect69.7K shares at avg. $27.60$1.9M - Jun 5, 2025CGON
CG Oncology, Inc.
AwardDirectDirector Stock Option (right to buy)
24.2K shares- - Dec 16, 2024CGON
CG Oncology, Inc.
SaleIndirect700K shares at avg. $28.00$19.6M - Oct 4, 2024CGON
CG Oncology, Inc.
AwardDirectStock Option (Right to Buy)
15.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2025 | CGON CG Oncology, Inc. | Sale | 100 | $28.99 | $2,899 | Indirect |
| Sep 3, 2025 | CGON CG Oncology, Inc. | Sale | 30,105 | $28.24 | $850,165 | Indirect |
| Sep 3, 2025 | CGON CG Oncology, Inc. | Sale | 100 | $28.96 | $2,896 | Indirect |
| Sep 3, 2025 | CGON CG Oncology, Inc. | Sale | 69,695 | $27.60 | $1,923,582 | Indirect |
| Jun 5, 2025 | CGON CG Oncology, Inc. | Award Director Stock Option (right to buy) | 24,165 | - | - | Direct |
| Dec 16, 2024 | CGON CG Oncology, Inc. | Sale | 700,000 | $28.00 | $19,600,000 | Indirect |
| Oct 4, 2024 | CGON CG Oncology, Inc. | Award Stock Option (Right to Buy) | 15,600 | - | - | Direct |
1-7 of 7 transactions